Future studies could be done to characterize DUSP16 expression levels and to correlate the status of JNK/p38 activation in the tumor tissues with the adjacent normal regions in chemosensitive and chemoresistant cancer patients. This evidence concerns the gene DUSP16 and neoplasm.